• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型铁死亡调控因子谷胱甘肽过氧化物酶 4 的别构激活剂。

Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4.

机构信息

Institute of Developmental Genetics , Helmholtz Zentrum München , 85764 Neuherberg , Germany.

Rudolf Virchow Center for Experimental Biomedicine , University of Würzburg , 97080 Würzburg , Germany.

出版信息

J Med Chem. 2019 Jan 10;62(1):266-275. doi: 10.1021/acs.jmedchem.8b00315. Epub 2018 May 2.

DOI:10.1021/acs.jmedchem.8b00315
PMID:29688708
Abstract

Glutathione peroxidase 4 (GPX4) is essential for cell membrane repair, inflammation suppression, and ferroptosis inhibition. GPX4 upregulation provides unique drug discovery opportunities for inflammation and ferroptosis-related diseases. However, rational design of protein activators is challenging. Until now, no compound has been reported to activate the enzyme activity of GPX4. Here, we identified a potential allosteric site in GPX4 and successfully found eight GPX4 activators using a novel computational strategy and experimental studies. Compound 1 from the virtual screen increased GPX4 activity, suppressed ferroptosis, reduced pro-inflammatory lipid mediator production, and inhibited NF-κB pathway activation. Further chemical synthesis and structure-activity relationship studies revealed seven more activators. The strongest compound, 1d4, increased GPX4 activity to 150% at 20 μM in the cell-free assay and 61 μM in cell extracts. Therefore, we demonstrated that GPX4 can be directly activated using chemical compounds to suppress ferroptosis and inflammation. Meanwhile, the discovery of GPX4 activators verified the possibility of rational design of allosteric activators.

摘要

谷胱甘肽过氧化物酶 4(GPX4)对于细胞膜修复、炎症抑制和铁死亡抑制至关重要。GPX4 的上调为炎症和铁死亡相关疾病的药物发现提供了独特的机会。然而,蛋白质激活剂的合理设计具有挑战性。到目前为止,还没有报道称有化合物能够激活 GPX4 的酶活性。在这里,我们鉴定了 GPX4 中的一个潜在别构位点,并成功使用一种新的计算策略和实验研究发现了八种 GPX4 激活剂。虚拟筛选出的化合物 1 增加了 GPX4 的活性,抑制了铁死亡,减少了促炎脂质介质的产生,并抑制了 NF-κB 通路的激活。进一步的化学合成和构效关系研究揭示了另外七种激活剂。最强的化合物 1d4 在无细胞测定中在 20μM 时将 GPX4 活性提高到 150%,在细胞提取物中提高到 61μM。因此,我们证明了可以使用化学化合物直接激活 GPX4 来抑制铁死亡和炎症。同时,GPX4 激活剂的发现验证了合理设计别构激活剂的可能性。

相似文献

1
Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4.新型铁死亡调控因子谷胱甘肽过氧化物酶 4 的别构激活剂。
J Med Chem. 2019 Jan 10;62(1):266-275. doi: 10.1021/acs.jmedchem.8b00315. Epub 2018 May 2.
2
Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy.激活谷胱甘肽过氧化物酶4作为一种新型抗炎策略。
Front Pharmacol. 2018 Oct 3;9:1120. doi: 10.3389/fphar.2018.01120. eCollection 2018.
3
Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.由谷胱甘肽过氧化物酶4(GPx4)调节的脂质过氧化依赖性细胞死亡与铁死亡
Curr Top Microbiol Immunol. 2017;403:143-170. doi: 10.1007/82_2016_508.
4
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.Nrf2 抑制逆转了头颈部癌症对 GPX4 抑制剂诱导的铁死亡的耐药性。
Free Radic Biol Med. 2018 Dec;129:454-462. doi: 10.1016/j.freeradbiomed.2018.10.426. Epub 2018 Oct 16.
5
Lipid Peroxidation and GPX4 Inhibition Are Common Causes for Myofibroblast Differentiation and Ferroptosis.脂质过氧化和 GPX4 抑制是肌成纤维细胞分化和铁死亡的常见原因。
DNA Cell Biol. 2019 Jul;38(7):725-733. doi: 10.1089/dna.2018.4541. Epub 2019 May 29.
6
Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage.谷胱甘肽过氧化物酶 4 通过介导脑出血大鼠模型中的铁死亡参与二次脑损伤。
Brain Res. 2018 Dec 15;1701:112-125. doi: 10.1016/j.brainres.2018.09.012. Epub 2018 Sep 8.
7
FINO initiates ferroptosis through GPX4 inactivation and iron oxidation.FINO 通过 GPX4 失活和铁氧化引发铁死亡。
Nat Chem Biol. 2018 May;14(5):507-515. doi: 10.1038/s41589-018-0031-6. Epub 2018 Apr 2.
8
Regulation of ferroptotic cancer cell death by GPX4.谷胱甘肽过氧化物酶 4 调控的亚铁死亡型癌细胞死亡
Cell. 2014 Jan 16;156(1-2):317-331. doi: 10.1016/j.cell.2013.12.010.
9
The Potency of Diarylamine Radical-Trapping Antioxidants as Inhibitors of Ferroptosis Underscores the Role of Autoxidation in the Mechanism of Cell Death.二芳基胺自由基捕获抗氧化剂作为铁死亡抑制剂的效力突出了自氧化在细胞死亡机制中的作用。
ACS Chem Biol. 2017 Oct 20;12(10):2538-2545. doi: 10.1021/acschembio.7b00730. Epub 2017 Sep 18.
10
GPX4 allosteric activators inhibit ferroptosis and exert myocardial protection in doxorubicin-induced myocardial injury mouse model.GPX4 变构激活剂抑制铁死亡并发挥心肌保护作用,在阿霉素诱导的心肌损伤小鼠模型中。
Eur J Med Chem. 2024 Nov 5;277:116721. doi: 10.1016/j.ejmech.2024.116721. Epub 2024 Jul 30.

引用本文的文献

1
Identification of energy metabolism and m6A-related gene clusters in Kashin-Beck disease based on bioinformatics analysis.基于生物信息学分析的大骨节病能量代谢与m6A相关基因簇的鉴定
BMC Musculoskelet Disord. 2025 Jul 22;26(1):697. doi: 10.1186/s12891-025-08922-3.
2
Noscapine derivative 428 suppresses ferroptosis through targeting GPX4.那可丁衍生物428通过靶向谷胱甘肽过氧化物酶4(GPX4)抑制铁死亡。
Redox Biol. 2025 Jun;83:103635. doi: 10.1016/j.redox.2025.103635. Epub 2025 Apr 12.
3
Natural flavonoids from herbs and nutraceuticals as ferroptosis inhibitors in central nervous system diseases: current preclinical evidence and future perspectives.
草药和营养保健品中的天然黄酮类化合物作为中枢神经系统疾病中的铁死亡抑制剂:当前的临床前证据及未来展望
Front Pharmacol. 2025 Mar 24;16:1570069. doi: 10.3389/fphar.2025.1570069. eCollection 2025.
4
Double-edged sword effect of GPX4 in skin homeostasis and diseases.谷胱甘肽过氧化物酶4(GPX4)在皮肤稳态与疾病中的双刃剑效应
Arch Dermatol Res. 2025 Feb 14;317(1):404. doi: 10.1007/s00403-025-03903-x.
5
Regulation of enzymatic lipid peroxidation in osteoblasts protects against postmenopausal osteoporosis.成骨细胞中酶促脂质过氧化的调节可预防绝经后骨质疏松症。
Nat Commun. 2025 Jan 17;16(1):758. doi: 10.1038/s41467-025-55929-4.
6
Ferroptosis: mechanisms and therapeutic targets.铁死亡:机制与治疗靶点。
MedComm (2020). 2024 Nov 20;5(12):e70010. doi: 10.1002/mco2.70010. eCollection 2024 Dec.
7
Mechanisms and Therapeutic Potential of GPX4 in Pain Modulation.谷胱甘肽过氧化物酶4(GPX4)在疼痛调节中的机制及治疗潜力
Pain Ther. 2025 Feb;14(1):21-45. doi: 10.1007/s40122-024-00673-8. Epub 2024 Nov 6.
8
A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.一种新型的铁死亡抑制剂,通宁甲素 A,通过激活 GPX4 来改善阿尔茨海默病。
Theranostics. 2024 Sep 23;14(16):6161-6184. doi: 10.7150/thno.98172. eCollection 2024.
9
Broadening horizons: the role of ferroptosis in polycystic ovary syndrome.拓宽视野:铁死亡在多囊卵巢综合征中的作用。
Front Endocrinol (Lausanne). 2024 Aug 2;15:1390013. doi: 10.3389/fendo.2024.1390013. eCollection 2024.
10
Ligandability at the Membrane Interface of GPx4 Revealed through a Reverse Micelle Fragment Screening Platform.通过反胶束片段筛选平台揭示的谷胱甘肽过氧化物酶4(GPx4)膜界面的配体结合能力
JACS Au. 2024 Jun 26;4(7):2676-2686. doi: 10.1021/jacsau.4c00427. eCollection 2024 Jul 22.